Historically, classical deficiencies of those vitamins were directly correlated with several pathological manifestations such as night blindness (due to Vitamin A deficiency), osteomalacia (due to Vitamin D deficiency), oxidative stress (due to Vitamin E deficiency), and hemorrhage (due to Vitamin K deficiency)
The switch is feasible and supported by clinical data
Metabolite abundance was detected relative to the internal standard and normalized to the protein content
Novo earned an approval for Wegovy in MASH earlier this year, but Andersen said its not a perfect fit for the condition, as it does not address the liver fibrosis that patients experience
But the FDAs decision signals a turning point for broader Medicare coverage of GLP-1s since Wegovy can now be used to reduce the risk of heart attack and stroke by people with cardiovascular disease and obesity or overweight, and not only as an anti-obesity drug
What an exciting time to be a researcher in this space